Curis, Inc., a therapeutic drug development company, focuses on the discovery, development, and commercialization of products that modulate key regulatory signaling pathways controlling the repair and regeneration of human tissues and organs. Its product development approach involves using small molecules, proteins, or antibodies to modulate these regulatory signaling pathways. Curis uses its product development approach to produce various preclinical product candidates in the fields of cancer, neurological disorders, kidney diseases, cardiovascular diseases, and hair growth regulation. The company is developing its product candidate programs in various signaling pathways, including the...